5Woywodt A, Haubitz M, Buchholz S, et al. Counting the cost markers of endothelial damage in hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2004, 34, 1015- 1023.
6Lee KW, Lip GY, Tayebjee M, et al. Circulating endothelial cells, yon Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes[J]. Blood, 2005, 105: 526-532.
4Woywodt A, Streiber F, de Groot K, et al. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet, 2003,361:206-210.
5Bull TM, Golpon H, Hebbel RP, et al. Circulating endothelial cells in pulmonary hypertension. Thromb Haemost, 2003, 90:698-703.
6Engstrom G, Lind P, Hedblad B, et al. Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men. Circulation, 2002,105: 2632-2637.
7Quilici J, Banzet N, Paule P, et al. Circulating endothelial cell count as a diagnostic marker for non-ST-elevation acute coronary syndromes. Circulation, 2004, 110: 1586-1591.
8Mutin M, Canavy I, Blann A, et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood, 1999, 93:2951-2958.
9Puhakka M, Magga J, Hietakorpi S, et al. Interleukin-6 and tumor necrosis factor alpha in relation to myocardial infarct size and collagen formation. J Cardiac Failure, 2003, 9:325-332.
10Makin AJ, Blann AD, Chung NAY, et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Eur Heart J, 2004, 25:371-376.
